Rathbones Group PLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 12.2% in the 4th quarter, HoldingsChannel reports. The firm owned 39,771 shares of the company’s stock after selling 5,532 shares during the period. Rathbones Group PLC’s holdings in HCA Healthcare were worth $18,567,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently modified their holdings of HCA. Pacer Advisors Inc. lifted its holdings in shares of HCA Healthcare by 6,115.3% during the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after buying an additional 896,437 shares in the last quarter. Viking Global Investors LP raised its position in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Danske Bank A S acquired a new position in HCA Healthcare during the third quarter valued at approximately $115,530,000. Zurich Insurance Group Ltd FI raised its position in HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock valued at $115,036,000 after purchasing an additional 262,912 shares in the last quarter. Finally, Mondrian Investment Partners LTD acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $106,605,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
Insider Transactions at HCA Healthcare
In other news, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.50% of the company’s stock.
HCA Healthcare Trading Up 2.5%
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were paid a $0.78 dividend. The ex-dividend date was Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.99%.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. Royal Bank Of Canada upped their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 price target on HCA Healthcare in a report on Monday, February 9th. Truist Financial raised their target price on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. The Goldman Sachs Group upped their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $537.73.
Read Our Latest Stock Analysis on HCA Healthcare
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
